Correlation Between Palantir Technologies and Isracann Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Palantir Technologies and Isracann Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Palantir Technologies and Isracann Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Palantir Technologies Class and Isracann Biosciences, you can compare the effects of market volatilities on Palantir Technologies and Isracann Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Palantir Technologies with a short position of Isracann Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Palantir Technologies and Isracann Biosciences.

Diversification Opportunities for Palantir Technologies and Isracann Biosciences

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Palantir and Isracann is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Palantir Technologies Class and Isracann Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Isracann Biosciences and Palantir Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Palantir Technologies Class are associated (or correlated) with Isracann Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Isracann Biosciences has no effect on the direction of Palantir Technologies i.e., Palantir Technologies and Isracann Biosciences go up and down completely randomly.

Pair Corralation between Palantir Technologies and Isracann Biosciences

Given the investment horizon of 90 days Palantir Technologies Class is expected to generate 0.28 times more return on investment than Isracann Biosciences. However, Palantir Technologies Class is 3.52 times less risky than Isracann Biosciences. It trades about 0.33 of its potential returns per unit of risk. Isracann Biosciences is currently generating about -0.22 per unit of risk. If you would invest  4,369  in Palantir Technologies Class on August 31, 2024 and sell it today you would earn a total of  2,236  from holding Palantir Technologies Class or generate 51.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns

Palantir Technologies Class  vs.  Isracann Biosciences

 Performance 
       Timeline  
Palantir Technologies 

Risk-Adjusted Performance

24 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Palantir Technologies Class are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. Even with relatively abnormal basic indicators, Palantir Technologies reported solid returns over the last few months and may actually be approaching a breakup point.
Isracann Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Isracann Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Palantir Technologies and Isracann Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Palantir Technologies and Isracann Biosciences

The main advantage of trading using opposite Palantir Technologies and Isracann Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Palantir Technologies position performs unexpectedly, Isracann Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Isracann Biosciences will offset losses from the drop in Isracann Biosciences' long position.
The idea behind Palantir Technologies Class and Isracann Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk